Published in Dtsch Arztebl Int on February 01, 2013
Correspondence (letter to the editor): Rehabilitation measures as therapeutic cornerstones. Dtsch Arztebl Int (2013) 0.93
Correspondence (letter to the editor): Reality not reflected. Dtsch Arztebl Int (2013) 0.92
Correspondence (letter to the editor): Cycle ergometry is not a reliable parameter. Dtsch Arztebl Int (2013) 0.91
Correspondence (reply): In reply. Dtsch Arztebl Int (2013) 0.75
Atherosclerosis--an inflammatory disease. N Engl J Med (1999) 59.28
Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med (2007) 25.17
Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med (2004) 19.42
Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med (2003) 13.29
Clinical end points in coronary stent trials: a case for standardized definitions. Circulation (2007) 10.31
A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med (1994) 9.15
Guidelines on myocardial revascularization. Eur Heart J (2010) 8.85
A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Engl J Med (1994) 7.96
Comparative effectiveness of revascularization strategies. N Engl J Med (2012) 5.49
Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease. N Engl J Med (2005) 4.64
ACC/AHA 2002 guideline update for exercise testing: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). J Am Coll Cardiol (2002) 4.48
Bare metal stent restenosis is not a benign clinical entity. Am Heart J (2006) 3.39
Safety and efficacy of drug-eluting and bare metal stents: comprehensive meta-analysis of randomized trials and observational studies. Circulation (2009) 2.40
Restenosis detected by routine angiographic follow-up and late mortality after coronary stent placement. Am Heart J (2004) 1.73
On the inappropriateness of noninvasive multidetector computed tomography coronary angiography to trigger coronary revascularization: a comparison with invasive angiography. JACC Cardiovasc Interv (2009) 1.66
Impact of restenosis 10 years after coronary angioplasty. Eur Heart J (1998) 1.59
Silent myocardial ischemia. Circulation (2003) 1.49
Transcarpal cardiac catheterization. Dtsch Arztebl Int (2009) 1.43
Different treatment options in chronic coronary artery disease: when is it the time for medical treatment, percutaneous coronary intervention or aortocoronary bypass surgery? Dtsch Arztebl Int (2009) 1.18
Impact of routine angiographic follow-up on the clinical benefits of paclitaxel-eluting stents: results from the TAXUS-IV trial. J Am Coll Cardiol (2006) 1.14
Prescription prevalence and continuing medication use for secondary prevention after myocardial infarction: the reality of care revealed by claims data analysis. Dtsch Arztebl Int (2011) 1.13
Predicting restenosis of drug-eluting stents placed in real-world clinical practice: derivation and validation of a risk model from the EVENT registry. Circ Cardiovasc Interv (2010) 0.99
[Percutaneous coronary interventions (PCI)]. Clin Res Cardiol (2008) 0.96
Clinical and angiographic predictors of restenosis after percutaneous coronary intervention: insights from the Prevention of Restenosis With Tranilast and Its Outcomes (PRESTO) trial. Circulation (2004) 0.96
Long-term outcomes after management of restenosis or thrombosis of drug-eluting stents. J Am Coll Cardiol (2006) 0.94
The clinical impact of routine angiographic follow-up in randomized trials of drug-eluting stents: a critical assessment of "oculostenotic" reintervention in patients with intermediate lesions. JACC Cardiovasc Interv (2010) 0.93
Noninvasive detection of atherosclerosis. N Engl J Med (1998) 0.92
[Diagnostic heart catheterization]. Clin Res Cardiol (2008) 0.87
Clinical assessment of atherosclerotic lesions: emerging from angiographic shadows. Circulation (2002) 0.80
2009 Focused updates to guidelines in ST-elevation myocardial infarction and percutaneous coronary intervention: application to interventional cardiology. JACC Cardiovasc Interv (2010) 0.79
Effects of Proprotein Convertase Subtilisin/Kexin Type 9 Antibodies in Adults With Hypercholesterolemia: A Systematic Review and Meta-analysis. Ann Intern Med (2015) 4.62
Concern Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery. Eur Heart J (2009) 3.14
(-)-Epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function in humans. Proc Natl Acad Sci U S A (2006) 3.03
The emerging biology of the nitrite anion. Nat Chem Biol (2005) 2.88
Impaired progenitor cell activity in age-related endothelial dysfunction. J Am Coll Cardiol (2005) 2.86
Plasma nitrite reflects constitutive nitric oxide synthase activity in mammals. Free Radic Biol Med (2003) 2.83
Impact of left ventricular lead position in cardiac resynchronization therapy on left ventricular remodelling. A circumferential strain analysis based on 2D echocardiography. Eur Heart J (2007) 2.59
Concomitant S-, N-, and heme-nitros(yl)ation in biological tissues and fluids: implications for the fate of NO in vivo. FASEB J (2002) 2.46
Red blood cells express a functional endothelial nitric oxide synthase. Blood (2005) 2.30
Nitrate and nitrite in biology, nutrition and therapeutics. Nat Chem Biol (2009) 2.29
Nitrite reductase activity of myoglobin regulates respiration and cellular viability in myocardial ischemia-reperfusion injury. Proc Natl Acad Sci U S A (2008) 2.17
Nitrite as regulator of hypoxic signaling in mammalian physiology. Med Res Rev (2009) 2.15
Sustained benefits in vascular function through flavanol-containing cocoa in medicated diabetic patients a double-masked, randomized, controlled trial. J Am Coll Cardiol (2008) 2.12
Erythrocytes are the major intravascular storage sites of nitrite in human blood. Blood (2005) 2.08
Safety and efficacy of deep sedation as compared to general anaesthesia in percutaneous mitral valve repair using the MitraClip system. Catheter Cardiovasc Interv (2014) 2.05
Meta-analysis of impact of different types and doses of statins on new-onset diabetes mellitus. Am J Cardiol (2013) 2.00
Plasma nitroso compounds are decreased in patients with endothelial dysfunction. J Am Coll Cardiol (2006) 1.91
Hemodialysis-induced release of hemoglobin limits nitric oxide bioavailability and impairs vascular function. J Am Coll Cardiol (2010) 1.89
Plasma nitrite concentrations reflect the degree of endothelial dysfunction in humans. Free Radic Biol Med (2005) 1.85
Nitrite reductase function of deoxymyoglobin: oxygen sensor and regulator of cardiac energetics and function. Circ Res (2007) 1.76
Concomitant presence of N-nitroso and S-nitroso proteins in human plasma. Free Radic Biol Med (2002) 1.71
Nitric oxide in myocardial ischemia/reperfusion injury. Cardiovasc Res (2004) 1.69
Vascular effects of cocoa rich in flavan-3-ols. JAMA (2003) 1.63
Impact of the metabolic syndrome on angiographic and clinical events after coronary intervention using bare-metal or sirolimus-eluting stents. Am J Cardiol (2007) 1.62
Relation of circulating Matrix Gla-Protein and anticoagulation status in patients with aortic valve calcification. Thromb Haemost (2009) 1.58
Microdialysis-based analysis of interstitial NO in situ: NO synthase-independent NO formation during myocardial ischemia. Cardiovasc Res (2007) 1.58
Decreased plasminogen activator inhibitor and tissue metalloproteinase inhibitor expression may promote increased metalloproteinase activity with increasing duration of human atrial fibrillation. J Cardiovasc Electrophysiol (2007) 1.57
Sirolimus-eluting stent treatment at high-volume centers confers lower mortality at 6-month follow-up: results from the prospective multicenter German Cypher Registry. Circulation (2009) 1.54
Left ventricular remodeling impairs coronary flow reserve in hypertensive patients. J Hypertens (2002) 1.53
Circulating nitrite contributes to cardioprotection by remote ischemic preconditioning. Circ Res (2014) 1.49
Improved endothelial function and decreased levels of endothelium-derived microparticles after transcatheter aortic valve implantation. EuroIntervention (2015) 1.45
Influence of percutaneous mitral valve repair using the MitraClip® system on renal function in patients with severe mitral regurgitation. Catheter Cardiovasc Interv (2014) 1.45
Blockade of angio-associated migratory cell protein inhibits smooth muscle cell migration and neointima formation in accelerated atherosclerosis. J Am Coll Cardiol (2008) 1.43
Evidence for in vivo transport of bioactive nitric oxide in human plasma. J Clin Invest (2002) 1.42
Comparative efficacy and safety of anticoagulant strategies for acute coronary syndromes. Comprehensive network meta-analysis of 42 randomised trials involving 117,353 patients. Thromb Haemost (2015) 1.40
Nitrite regulates hypoxic vasodilation via myoglobin-dependent nitric oxide generation. Circulation (2012) 1.40
Acute consumption of flavanol-rich cocoa and the reversal of endothelial dysfunction in smokers. J Am Coll Cardiol (2005) 1.36
Myocardial deformation imaging based on ultrasonic pixel tracking to identify reversible myocardial dysfunction. J Am Coll Cardiol (2008) 1.32
Cocoa polyphenols and inflammatory mediators. Am J Clin Nutr (2005) 1.31
NO adducts in mammalian red blood cells: too much or too little? Nat Med (2003) 1.30
Real-time three-dimensional transoesophageal echocardiography for guidance of non-coronary interventions in the catheter laboratory. Eur J Echocardiogr (2009) 1.25
Advanced speckle tracking echocardiography allowing a three-myocardial layer-specific analysis of deformation parameters. Eur J Echocardiogr (2008) 1.24
Peritoneal dialysis relieves clinical symptoms and is well tolerated in patients with refractory heart failure and chronic kidney disease. Eur J Heart Fail (2012) 1.20
Griess method for nitrite measurement of aqueous and protein-containing samples. Methods Enzymol (2002) 1.15
Circulating NO pool: assessment of nitrite and nitroso species in blood and tissues. Free Radic Biol Med (2004) 1.15
Flavanols and cardiovascular disease prevention. Eur Heart J (2010) 1.15
Prevention of dipyrone (metamizole) induced inhibition of aspirin antiplatelet effects. Thromb Haemost (2015) 1.14
Gene expression analysis of human red blood cells. Int J Med Sci (2009) 1.13
Augmentation of left ventricular contractility by cardiac sympathetic neural stimulation. Circulation (2010) 1.12
Incidence and predictors of target vessel revascularization and clinical event rates of the sirolimus-eluting coronary stent (results from the prospective multicenter German Cypher Stent Registry). Am J Cardiol (2005) 1.11
Human red blood cells at work: identification and visualization of erythrocytic eNOS activity in health and disease. Blood (2012) 1.11
Plasma nitrosothiols contribute to the systemic vasodilator effects of intravenously applied NO: experimental and clinical Study on the fate of NO in human blood. Circ Res (2002) 1.11
Dietary nitrate supplementation improves revascularization in chronic ischemia. Circulation (2012) 1.10
Cardioprotection through S-nitros(yl)ation of macrophage migration inhibitory factor. Circulation (2012) 1.10
A giant pericardial cyst as unusual cause for atrial flutter. J Am Coll Cardiol (2010) 1.10
Positive effects of nitric oxide on left ventricular function in humans. Eur Heart J (2006) 1.10
Transplantation of endothelial progenitor cells improves neovascularization and left ventricular function after myocardial infarction in a rat model. Basic Res Cardiol (2007) 1.09
Hypoxia impairs systemic endothelial function in individuals prone to high-altitude pulmonary edema. Am J Respir Crit Care Med (2005) 1.09
Real-time transesophageal three-dimensional echocardiography for guidance of percutaneous cardiac interventions: first experience. Clin Res Cardiol (2008) 1.05
A prospective study on incidence and risk factors of arteriovenous fistulae following transfemoral cardiac catheterization. Int J Cardiol (2003) 1.05
Age-dependent endothelial dysfunction is associated with failure to increase plasma nitrite in response to exercise. Basic Res Cardiol (2008) 1.04
RBC NOS: regulatory mechanisms and therapeutic aspects. Trends Mol Med (2008) 1.04
Circulating blood endothelial nitric oxide synthase contributes to the regulation of systemic blood pressure and nitrite homeostasis. Arterioscler Thromb Vasc Biol (2013) 1.04
Thiols enhance NO formation from nitrate photolysis. Free Radic Biol Med (2003) 1.03
Impact of infarct transmurality on layer-specific impairment of myocardial function: a myocardial deformation imaging study. Eur Heart J (2009) 1.02
Impaired endothelial progenitor cell function predicts age-dependent carotid intimal thickening. Basic Res Cardiol (2008) 1.01
The angiotensin-calcineurin-NFAT pathway mediates stretch-induced up-regulation of matrix metalloproteinases-2/-9 in atrial myocytes. Basic Res Cardiol (2009) 1.01
Myocardial T2 mapping reveals age- and sex-related differences in volunteers. J Cardiovasc Magn Reson (2015) 1.00
Dipyrone (metamizole) can nullify the antiplatelet effect of aspirin in patients with coronary artery disease. J Am Coll Cardiol (2013) 1.00
Impact of left ventricular loading conditions on myocardial deformation parameters: analysis of early and late changes of myocardial deformation parameters after aortic valve replacement. J Am Soc Echocardiogr (2007) 0.99
Blockade of atrial-specific K+-currents increases atrial but not ventricular contractility by enhancing reverse mode Na+/Ca2+-exchange. Cardiovasc Res (2006) 0.99
Nitric oxide differentially regulates proliferation and mobilization of endothelial progenitor cells but not of hematopoietic stem cells. Thromb Haemost (2005) 0.98
Recovery of neutrophil apoptosis by ectoine: a new strategy against lung inflammation. Eur Respir J (2012) 0.98
Sustained increase in flow-mediated dilation after daily intake of high-flavanol cocoa drink over 1 week. J Cardiovasc Pharmacol (2007) 0.97
Plasma nitrite reserve and endothelial function in the human forearm circulation. Free Radic Biol Med (2006) 0.97
Nitric oxide synthase-derived plasma nitrite predicts exercise capacity. Br J Sports Med (2007) 0.96
MDCT detection of mitral valve calcification: prevalence and clinical relevance compared with echocardiography. AJR Am J Roentgenol (2007) 0.96
Improved left ventricular function after transplantation of microspheres and fibroblasts in a rat model of myocardial infarction. Basic Res Cardiol (2009) 0.94
Valve-in-valve implantation of Medtronic CoreValve prosthesis in patients with failing bioprosthetic aortic valves. Circ Cardiovasc Interv (2012) 0.94
Association of echocardiographic atrial size and atrial fibrosis in a sequential model of congestive heart failure and atrial fibrillation. Cardiovasc Pathol (2008) 0.94
Myocardial T2 Mapping Increases Noninvasive Diagnostic Accuracy for Biopsy-Proven Myocarditis. JACC Cardiovasc Imaging (2016) 0.92
Relation of optimal lead positioning as defined by three-dimensional echocardiography to long-term benefit of cardiac resynchronization. Am J Cardiol (2007) 0.92
Rapid and accurate determination of relative infarct size in humans using contrast-enhanced magnetic resonance imaging. Clin Res Cardiol (2009) 0.92
Recent methodological advances in the analysis of nitrite in the human circulation: nitrite as a biochemical parameter of the L-arginine/NO pathway. J Chromatogr B Analyt Technol Biomed Life Sci (2007) 0.91
Primary and secondary prevention of ventricular arrhythmias in dilated cardiomyopathy: nonsustained, sustained, and incessant. Int Heart J (2009) 0.91
Whole body UVA irradiation lowers systemic blood pressure by release of nitric oxide from intracutaneous photolabile nitric oxide derivates. Circ Res (2009) 0.91
New functional aspects of the L-arginine-nitric oxide metabolism within the circulating blood. Thromb Haemost (2007) 0.91
Desferoxamine and ethyl-3,4-dihydroxybenzoate protect myocardium by activating NOS and generating mitochondrial ROS. Am J Physiol Heart Circ Physiol (2005) 0.91
A multilevel analytical approach for detection and visualization of intracellular NO production and nitrosation events using diaminofluoresceins. Free Radic Biol Med (2012) 0.91
Dietary inorganic nitrate mobilizes circulating angiogenic cells. Free Radic Biol Med (2012) 0.90
Nitric oxide influences red blood cell velocity independently of changes in the vascular tone. Free Radic Res (2011) 0.90
Enzyme-independent nitric oxide formation during UVA challenge of human skin: characterization, molecular sources, and mechanisms. Free Radic Biol Med (2005) 0.89
Flavanols and cardiovascular health: effects on the circulating NO pool in humans. J Cardiovasc Pharmacol (2006) 0.89
Quantitative analysis of endocardial and epicardial left ventricular myocardial deformation-comparison of strain-encoded cardiac magnetic resonance imaging with two-dimensional speckle-tracking echocardiography. J Am Soc Echocardiogr (2012) 0.89
Advanced cardiac imaging in percutaneous transvenous mitral annuloplasty. Clin Res Cardiol (2010) 0.88
Regulation of nerve growth factor in the heart: the role of the calcineurin-NFAT pathway. J Mol Cell Cardiol (2008) 0.88